Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

UiPath appears to be struggling with making the Agentic AI potential show up on the balance sheet. Click here to read an analysis of PATH stock now.

We recently published a list of the 13 Best Artificial Intelligence Stocks Under $50 to Buy Now. In this article, we are ...

C3.ai, Inc. and UiPath Inc. are both high-profile players in the booming AI automation sector. C3.ai specializes in ...

In this features, UiPath Chief People Officer Agnes Garaba, reveals how the company’s HR team is reshaping the future of work by emotional intelligence with agentic AI.

UiPath's FY26E and FY27E revenue projections are modestly above Street due to underappreciated core platform resilience. Read ...